Hudock, Inc. Moderna, Inc. Transaction History

Hudock, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $252 - $470	2 Added 1.32%	153 $26,000
Q4 2021 Jan 19, 2022	SELL	$225.82 - $368.51 $3,838 - $6,264	-17 Reduced 10.12%	151 $38,000
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $3,106 - $6,782	-14 Reduced 7.69%	168 $64,000
Q2 2021 Aug 09, 2021	SELL	$129.91 - $234.98 $259 - $469	-2 Reduced 1.09%	182 $42,000
Q1 2021 Apr 26, 2021	BUY	$109.18 - $185.98 $3,166 - $5,393	29 Added 18.71%	184 $24,000
Q4 2020 Feb 05, 2021	BUY	$65.74 - $169.86 $10,189 - $26,328	155 New	155 $16,000
Q4 2019 Jan 21, 2020	SELL	$13.93 - $21.28 $15,267 - $23,322	-1,096 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$12.26 - $18.07 $13,436 - $19,804	1,096 New	1,096 $17,000
Q1 2019 Apr 23, 2019	SELL	$14.45 - $23.7 $14,450 - $23,700	-1,000 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$13.52 - $18.8 $13,520 - $18,800	1,000 New	1,000 $14,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.